LIGAND PHARMACEUTICALS INC. - SC13G - 12-2-05

Company

LIGAND PHARMACEUTICALS INC

Filed

December 6, 2005

Accession Number

0000902664-05-002322

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →